Stephen Binsse, Jacques Sellier, Jérome Lucas, Mostafa El Hajjam, Pascal Lacombe

Similar documents
Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH

International Journal of Diagnostic Imaging, 2014, Vol. 1, No. 2

New Definition and Natural History of Patients With Diffuse Pulmonary Arteriovenous Malformations*

Neurologic Manifestation as Initial Presentation in a Case of Hereditary Haemorrhagic Telangiectasia

Endovascular Management of Pulmonary Arteriovenous Malformation

Pulmonary arteriovenous malformations (PAVMs)

.. CHEST Original Research

Life expectancy of parents with Hereditary Haemorrhagic Telangiectasia

Embolotherapy for Pulmonary Arteriovenous Malformations in Patients without Hereditary Hemorrhagic Telangiectasia

(received 8 March 2013, accepted 15 April 2013)

Impact of Pulmonary Arteriovenous Malformations on Respiratory Related Quality of Life in Patients with Hereditary Haemorrhagic Telangiectasia

Pulmonary arteriovenous malformations presenting as difficult-to-control asthma: a case report

Where is the Origin of the Last Normal Branch from Feeding Artery of Pulmonary Arteriovenous Malformations?

Pulmonary Arteriovenous Malformations Complicated with Paradoxical Embolic Stroke

Chapter. Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension

Endovascular treatment of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia

Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls

Severity score for hereditary hemorrhagic telangiectasia

Hereditary Hemorrhagic Telangiectasia or Osler-Weber -Rendu Syndrome: Management of Epistaxis in 4 Cases.

YES NO UNKNOWN. Stage I: Rule-Out Dashboard ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above)

Association between reperfusion and shrinkage percentage of aneurysmal sac after

Graded contrast echocardiography in pulmonary arteriovenous malformations

Pulmonary Arteriovenous Malformations And Osler Weber Rendu Syndrome: An Unusual Cause Of Dyspnea

Cerebral abscesses among Danish patients with hereditary haemorrhagic telangiectasia

Preliminary experience with the micro vascular plug for the treatment of pulmonary arteriovenous malformation: case series of four patients

Intractable & Rare Diseases Research. 2018; 7(4):

You Won t Believe What I Saw on. Disclosures. Goals. Dimensions 2013 October 18 th Michael Pfeiffer, MD. No Financial Disclosures

L angiografia ha ancora un ruolo?

Role of Transthoracic Contrast Echocardiography in the Clinical Diagnosis of Hereditary Hemorrhagic Telangiectasia

Treating Pulmonary Arteriovenous Malformations: What to Do and What Not to Do

Pulmonary arteriovenous fistula

An Evaluation of the Severity and Progression of Epistaxis in Hereditary Hemorrhagic Telangiectasia 1 Versus Hereditary Hemorrhagic Telangiectasia 2

Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia

Genotype phenotype relationship in Hereditary Hemorrhagic Telangiectasia

Anatomy, Physiology and Management of Patients with Diffuse Pulmonary Arteriovenous Malformations

Life expectancy in patients with hereditary haemorrhagic telangiectasia

Pulmonary arteriovenous malformations: endovascular therapy

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11

Pulmonary Arteriovenous Malformations: Current Technique of Transcatheter Embolization and Subsequent Management

Concurrent Subarachnoid Hemorrhage and Acute Myocardial Infarction: A Case Report

1. Introduction. Central European Journal of Medicine. Sadık Kadri Açikgöz 1, Gülten Taçoy 1*, Baran Önal 2, Beytullah Yıldırım 3, Atiye Çengel 1

Reproducibility Of Exercise Testing In Patients With Pulmonary Arteriovenous Malformations

Common bleeding disorders affecting individuals with Hereditary Hemorrhagic Telangiectasia

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Hereditary haemorrhagic telangiectasia

Targeting under-diagnosis in hereditary hemorrhagic telangiectasia: a model approach for rare diseases?

An Epistaxis Severity Score for Hereditary Hemorrhagic Telangiectasia

Subclavian artery Stenting

Thrombosis and emboli. Peter Nagy

Orphanet Journal of Rare Diseases 2012, 7:33

Rendu-Osler-Weber Syndrome: A Case Report

HEMOPTYSIS. Prof. G. Zuliani

A Case Report of Hereditary Hemorrhagic Telangiectasia (HHT)

Delayed Intracranial Air Embolism After Interventional Therapy of Congenital Pulmonary Arteriovenous Fistula

Pulmonary arteriovenous malformations (PAVMs)

Case Report Hereditary Hemorrhagic Telangiectasia with Hepatic Vascular Malformations

Lung diseases of Vascular Origin. By: Shefaa Qa qqa

Diaphragmatic Hernia Presenting With Intrathoracic Perforation

H ereditary haemorrhagic telangiectasia (HHT, Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century REVIEW

Note: This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, cont

Comorbidity among HHT patients and their controls in a 20 years follow-up period

MANAGING PASSENGERS WITH RESPIRATORY BRITISH THORACIC SOCIETY RECOMMENDATIONS DISEASE PLANNING AIR TRAVEL:

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

Definition: HPS is a disease process with a triad of: 1- Liver disease. 2- Widespread intrapulmonary vasodilatation. 3- Gas exchange abnormality prese

Surgical indications: Non-malignant pulmonary diseases. Punnarerk Thongcharoen

Appendix to Gibson et al. Application of a decision rule and a D-dimer assay in the

Luisa Vinciguerra. Ictus recidivanti

Cystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012

Rendu Osler Weber disease or Hereditary Hemorrhagic Telangiectasia (HHT): liver vascular involvement

Angel J. Lacerda MD PhD, Daisy Abreu MD, Julio A. Díaz MD, Sandro Perez MD, Julio C Martin MD, Daiyan Martin MD.

Rendu-Osler-Weber Syndrome or Hereditary Hemorrhagic Telangiectasia (HHT): Report of two cases and review of literature

How pregnancy impacts adult cyanotic congenital heart disease

Case Report A novel germline mutation in SMAD4 gene in a hereditary hemorrhagic telangiectasia family

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

Distinct Forms of Pulmonary Hypertension Complicate Hereditary Hemorrhagic Telangiectasia

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013


Extra Corporeal Life Support for Acute Heart failure

Pulmonary arteriovenous malformations and other pulmonary. aspects of hereditary haemorrhagic telangiectasia

Pulmonary Embolism. Thoracic radiologist Helena Lauri

Overview of reports of thromboembolic adverse drug reactions associated with cyproterone/ethinylestradiol

ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

Patient Management Code Blue in the CT Suite

A Repeat Case of Idiopathic Spontaneous Hemothorax

Cardiopulmonary aspects of hereditary haemorrhagic telangiectasia

Acute abdominal venous thromboses- the hyperdense noncontrast CT sign

A Case of Carotid-Cavernous Fistula

A 50-year-old woman with syncope

CLEAR III TRIAL : UPDATE ON SURGICAL MATTERS THAT MATTER

HEMODYNAMIC DISORDERS

CNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 7: Non traumatic brain haemorrhage

Pathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University

Individual Pulmonary Vein Atresia in Adults: Report of Two Cases

The Management and Treatment of Ruptured Abdominal Aortic Aneurysm (RAAA)

Brain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage

Unilateral pulmonary oedema, a forgotten presentation.

Thrombolytic therapy should be the first line treatment in acute ishchemic stroke. We are against it!!

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Takotsubo Cardiomyopathy: Pathophysiology and Assessment

Results of the TRAIL Multicenter, Observational Study. Michel Piotin, Christina Iosif, Charbel Mounayer for the TRAIL Investigator Group

Transcription:

SPONTANEOUS RUPTURE OF PULMONARY ARTERIOVENOUS MALFORMATIONS IN HEREDITARY HAEMORRHAGIC TELANGIECTASIA (HHT) REVIEW OF 12 CASES Stephen Binsse, Jacques Sellier, Jérome Lucas, Mostafa El Hajjam, Pascal Lacombe HHT Center of Paris, Hôpital Ambroise Paré, Université Versailles St Quentin en Yvelines

Stephen Binsse No relevant financial relationship reported

PULMONARY ARTERIOVENOUS MALFORMATIONS Most complications in HHT are related to PAVM Dyspnea, cyanosis, clubbing in diffuse or large PAVMs Paradoxical embolism: TIA, stroke, brain abscess Life-threatening hemorrhage due to rupture of PAVM Faughnan, and al. Eur Respir J 2009; 33: 11894

PURPOSE To describe clinical presentation, imaging findings and therapeutics options in patients with spontaneously ruptured PAVMs

MATERIAL AND METHODS All consecutive patients with rupture of PAVMs were recorded from our database and reviewed retrospectively 12-year inclusion time Age, clinical presentation Imaging (Chest X-ray, MDCT) findings Embolization and results

RESULTS 970 patients evaluated at our HHT center, 425 patients with PAVMs. 12 patients identified with spontaneous rupture of PAVM - 9 adults and 3 children - 6 women per 6 men - Mean age : 41 years (range 10-82) - 10 of them already diagnosed with HHT - Diagnosis of HHT (mutation) confirmed in 8/12

CLINICAL PRESENTATION 6 patients with hemoptysis, associated with neurological symptoms in 3 patients - TIA in 2 cases - Loss of consciousness in 1 case 6 patients with acute chest pain

IMAGING FINDINGS Hemothorax in 6 patients and intra-parenchymal ruptures in 6 patients. Average diameter of feeding artery: 6.7 mm (min 2- max 12). Recanalisation of previously embolized PAVMs in 3 patients. Signs of pulmonary arterial hypertension (PAH) in 4 patients.

THERAPEUTIC MANAGEMENT AND FOLLOW-UP 11 patients successfully treated by prompt embolization. One patient died of massive hemothorax.

57 y.o. w., acute chest pain during flight Clot Intra-pleural herniation

Acute chest pain Intra-pleural herniation Intra-pleural herniation

Hemoptysis and TIA 37 y.o. man, with diagnosed HHT, admitted because of transient hemiplegia and hemoptysis. CT-scan show intra-parenchymal bleeding by rupture of a PAVM located within the right anterior basal segment.

Embolization of the feeding artery (A8) using fibered steel coils

Central recanalization Side-branch

Discussion Second description of the occurrence of thoracic hemorrhage in a large series of patients with PAVM and HHT Database of 246 patients embolized for PAVMs 11 (8%) with massive hemoptysis or hemothorax 5 hemoptysis (3 men/2 women, age 15-59) - 2 deaths, 2 lobectomies, 1 emergent C-section 5 hemothorax (1 man/4 women, age 19-62) - Drainage 1 patient with both Total 7 women including 3 (43%) ruptures during pregnancy Ference et al. Chest 1994;106:1387-90

Discussion: clinical presentation Acute chest pain often associated with respiratory failure: pleural rupture. Hemoptysis and neurological signs: intraparenchymal rupture

Discussion: risk factors Outcome analysis and determination of risk factors not possible (retrospective study, low number of cases) Diameter of feeding artery higher than 3mm Pregnancy Pulmonary hypertension

Known growth factors of PAVM Pregnancy Just before pregnancy After delivery

Known growth factors of PAVM PAH before Two years later

Pregnancy Known as risk factor in third trimester Increase of blood volume and cardiac output, inducing an higher flow through PAVM. Laroche and al. Chest 1992;101:1452-54 Shovlin and al. BJOG 2008; 115 (9):11108-1115

PAH 4 patients in our study, all with hemothorax, 1 died before embolization. Embolization of PAVM is not usually recommended because risk of worsening PAH. Significant risk of rupture and life threatening hemorrhage. PAVMs embolization might be considered in patients with stable PAH.

Diameter of feeding artery > 3mm All ruptured PAVM but one in our study (average 6,7mm). International Guidelines: embolization recommended in PAVM feeded by artery which are 2.5 to 3mm or larger in diameter.

CHILDHOOD 3 cases in our study (15, 15 and 10 years). 1 case in the Ference s study (died suddenly). No study already described the influence of puberty on PAVMs growth.

Spontaneous rupture without risk factor 32 y.o. woman with hemoptysis: no pregnancy, no PAH, no diving, feeding artery diameter was only 2mm. Treated by embolization.

CONCLUSION Rupture of PAVM should be suspected in case of chest pain or hemoptysis typically associated with neurological manifestations due to gas emboli or clot emboli during cough (other embolic situations like coronary ischemia can be encountered). Rare event: 4% in our experience Emergent embolization is effective Rupture should be prevented by prophylactic embolization of PAVMs larger than 2.5mm.

CONCLUSION Pregnancy and PAH increase the risk of rupture by increasing the size of PAVMs Screening of PAVM and embolization in pregnancyseeking women is required. Low-dose MDCT control 6 months after delivery. PAVMs embolization might be considered in patients with PAH, using test by transient balloon occlusion prior to embolization in case of severe PAH. Spontaneous rupture of PAVM can occur at any age, without any of these risk factors.

REFERENCES Ference B, Shannon T, White R, Zawin M, Burdge C. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary malformations and hereditary hemorrhagic telangiectasia. Chest 1994; 106:1387-1390. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff U W, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo J F, Picus D, Plauchu H, Porteous MEM, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJJ, White RI, Young LH, Zarrabeitia R. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011; 48:73-87. Shovlin CL, Winstock AR, Peters AM, et al: Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. Q J Med 88:879 887, 1995. Simonneau G, Galie N, Rubin L, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: Suppl.12, 5S-12S. LetteboerTG, Mager JJ, Snijder RJ, et al. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J med genet 2006; 43:371-377. Kurzyna M, Babrowski M, Bielecki D, et al. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest 2007; 131:977-983. Montani D, Price LC, Girerd B, Chinet T, Lacombe P, Simonneau G, Humebert M. Fatal rupture of pulmonary arterioveinousmalformation in hereditary haemorrhagic telangiectasis and severe PAH. Eur RespirRev2009; 18: 11, 42-46. Shovlin CL, Tighe HC, Davies RJ, Gibbs JS, Jackson JE. Embolisation of pulmonary arterioveinous malformations: no consistent effect on pulmonary artery pressure. Eur respire J 2008; 32: 162-169. Shovlin CL, Winstock AR, Peters AM, Jackson JE, Hughes JM. Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. QJmed 1995 Dec; 88:879-87. Shovlin CL, Jackson JE, Bamford KB, et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 2008; 63: 259 266.